Trials / Completed
CompletedNCT00387309
Study Evaluating IV Methylnaltrexone for the Treatment of Post Operative Ileus
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Intravenous Methylnaltrexone (MOA-728) for the Treatment of Post Operative Ileus.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 495 (planned)
- Sponsor
- Bausch Health Americas, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Primary Objective: In subjects who have undergone segmental colectomy, the time between the end of surgery and first bowel movement is significantly shorter with the investigational MOA-728 regimen than with a placebo regimen.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Methylnaltrexone (MOA-728) |
Timeline
- Start date
- 2006-12-01
- Completion
- 2007-11-01
- First posted
- 2006-10-13
- Last updated
- 2019-11-25
Locations
92 sites across 10 countries: United States, Australia, Germany, Hungary, Italy, Poland, Romania, Serbia and Montenegro, South Africa, South Korea
Source: ClinicalTrials.gov record NCT00387309. Inclusion in this directory is not an endorsement.